North Carolina may lose pharma project after passing law targeting LGBT community

Two weeks ago North Carolina governor Gov. Pat McCrory was pointing to a proposed project by New Jersey-based Braeburn Pharmaceuticals and bragging about what a great job the state has done attracting pharma companies. But Braeburn is having second thoughts about the state after the governor last week signed a bill that eliminated local protections for gay and transgender people and limits the bathroom choices they have. In a statement to WNCN in Durham, NC, Braeburn called the law "unjust. It is slated to receive up to $275,000 in incentives for the project. "Braeburn Pharmaceuticals believes in fair treatment and equality for all individuals in their communities. We oppose any legislation that discriminates against the LGBT community," the company said. More from FiercePharmaManufacturing

Suggested Articles

AZ's tremelimumab has so far suffered a host of clinical failures. But new trial results show the company might be able to use the drug in a new way.

Roche may have just grabbed the first FDA nod for a checkpoint med in previously untreated liver cancer, but Merck is hoping it won’t be far behind.

Pfizer’s Ibrance has met with success in breast cancer since breaking onto the scene in 2015. But its first foray into early breast cancer was a bust.